[Wiley] Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double©Blind, Phase 3 POETYK PsA |
|
This post will be closed automatically in 2026-08-29 17:48
Reward10points
|
post
reply
points
2771
20
Reframing Osteoblast Homeostasis as a Systemic Endocrine¨CMetabolic Node: Mechanisms, Inter©Organ Crosstalk, and Translational Strategies
10
Multimodal Operando Analysis of Lithium Sulfur Multilayer Pouch Cells: An In©Depth Investigation on Cell Component Design and Performance
10
Tactile Paving Detection and Tracking Using Tenji10K Dataset
10
Safety and Efficacy of Ianalumab in Patients With Sjgren's Disease: 52©Week Results From a Randomized, Placebo©Controlled, Phase 2b Dose©Ranging Study
10
Pharmacokinetics of subcutaneous and intravenous bolus doses of morphine in palliative care cancer patients receiving infusion of morphine: A pharmacokinetic substudy of a randomized controlled trial
